Table of Content
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in oncology dealmaking
2.1. Introduction
2.2. Oncology partnering over the years
2.3. Oncology partnering by deal type
2.4. Oncology partnering by industry sector
2.5. Oncology partnering by stage of development
2.6. Oncology partnering by technology type
2.7. Oncology partnering by therapeutic indication
Chapter 3 – Financial deal terms for oncology partnering
3.1. Introduction
3.2. Disclosed financials terms for oncology partnering
3.3. Oncology partnering headline values
3.4. Oncology deal upfront payments
3.5. Oncology deal milestone payments
3.6. Oncology royalty rates
Chapter 4 – Leading oncology deals and dealmakers
4.1. Introduction
4.2. Most active in oncology partnering
4.3. List of most active dealmakers in oncology
4.4. Top oncology deals by value
Chapter 5 – Oncology contract document directory
5.1. Introduction
5.2. Oncology partnering deals where contract document available
Chapter 6 – Oncology dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by oncology therapeutic target
Deal directory
Deal directory – Oncology deals by company A-Z 2019 to 2023
Deal directory – Oncology deals by technology type 2019 to 2023
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering
Table of figures
Figure 1: Oncology partnering since 2019
Figure 2: Oncology partnering by deal type since 2019
Figure 3: Oncology partnering by industry sector since 2019
Figure 4: Oncology partnering by stage of development since 2019
Figure 5: Oncology partnering by technology type since 2019
Figure 6: Oncology partnering by indication since 2019
Figure 7: Oncology deals with a headline value
Figure 8: Oncology deals with upfront payment values
Figure 9: Oncology deals with milestone payment
Figure 10: Oncology deals with royalty rates
Figure 11: Active oncology dealmaking activity since 2019
Figure 12: Top oncology deals by value since 2019
US $
Euro €
GBP £